JCSE01.09 Cluster Trial: Ph2 Biomarker-Integrated Study of Single Agent Alpelisib, Capmatinib, Ceritinib and Binimetinib in advNSCLC

Subjects

Subjects :

Pulmonary and Respiratory Medicine
Oncology
medicine.medical_specialty
Capmatinib
Ceritinib
business.industry
Binimetinib
Disease cluster
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
chemistry
030220 oncology & carcinogenesis
Internal medicine
medicine
Biomarker (medicine)
Single agent
business
030217 neurology & neurosurgery
medicine.drug

Details

ISSN :

15560864

Volume :

13

Database :

OpenAIRE

Journal :

Journal of Thoracic Oncology

Accession number :

edsair.doi...........cb3295e5d6f0bf90ee4e711cc0dff020

Full Text :

https://doi.org/10.1016/j.jtho.2018.08.217